CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,200.60
+48.60 (2.26%)
Last updated: Oct 28, 2026, 3:29 PM IST
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 134.59 billion as of October 28, 2026. It is the 8,211th most valuable company in the world and the 485th biggest in India.
Market Cap
134.59B
Enterprise Value
135.95B
Revenue
14.79B
Global Rank
Country Rank
#485 India
PE Ratio
67.61
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 134.59B, an increase of 52.99%. That is a compound annual growth rate of 63.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 134.59B | 58.90% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Divi's Laboratories | 2.54T |
| Lenskart Solutions | 1.20T |
| Laurus Labs | 1.18T |
| Molbio Diagnostics | 150.32B |
| Vijaya Diagnostic Centre | 148.52B |
| Indegene | 144.06B |
| Marksans Pharma | 138.10B |